Pyrrole

Pyrrole

SCHEMBL22412640

[Br-].[H+].c1cc[nH]c1

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1

The experimentally established mechanism targets of Pyrrole. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Pyrrole SCHEMBL2579859 0.95 — —
Pyrrole SCHEMBL23327323 0.95 — —
Pyrrole SCHEMBL28316287 0.90 — —
Pyrrole SCHEMBL7973127 0.90 — —
Pyrrole SCHEMBL27535135 0.89 — —
Pyrrole SCHEMBL2885785 0.89 — —
Pyrrole SCHEMBL14840876 0.89 — —
Pyrrole SCHEMBL15757584 0.89 — —
Pyrrole SCHEMBL841068 0.89 — —
Pyrrole SCHEMBL15801170 0.89 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3938345-A1 CHARGED ION CHANNEL BLOCKERS AND METHODS FOR USE Nocion Therapeutics, Inc. (US) 2022-01-19 — — EP disclosed
WO-2020185830-A1 CHARGED ION CHANNEL BLOCKERS AND METHODS FOR USE Nocion Therapeutics, Inc. (US) 2020-09-17 — — WO disclosed
Send feedback